Release Date: 29/07/11 08:30 Summary: Quarterly Activities and Cashflow Reports Price Sensitive: Yes Download Document 606.34KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%